Dexamethasone increases plasma HVA but not MHPG in normal humans
- PMID: 3865250
- DOI: 10.1016/0165-1781(85)90003-4
Dexamethasone increases plasma HVA but not MHPG in normal humans
Abstract
Several recent studies in animals and man indicate that corticosteroids may alter catecholaminergic activity in both the peripheral and central nervous systems. We administered 1 mg of the synthetic glucocorticoid, dexamethasone, to 12 drug-free healthy volunteers and measured plasma homovanillic acid (HVA) and 3-methoxy-4-hydroxyphenylglycol (MHPG). Dexamethasone was administered at 11 p.m. and blood was collected at 4 p.m. on the preceding and subsequent days. Dexamethasone administration resulted in a significant increase in plasma HVA but did not consistently affect MHPG. All subjects showed a suppression of serum cortisol to values less than 5 micrograms/dl while prolactin levels were unaltered. In an additional group of nine volunteers, we administered 2 mg of dexamethasone and observed a similar increase in plasma HVA without change in plasma MHPG, indicating a selective effect on dopamine metabolism. Implications of these findings for an understanding of the neurochemical and behavioral changes seen with steroid administration and in explaining previous results on plasma MHPG/HVA ratios in delusional depression are discussed.
Similar articles
-
The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.Arch Gen Psychiatry. 1987 Sep;44(9):782-9. doi: 10.1001/archpsyc.1987.01800210026004. Arch Gen Psychiatry. 1987. PMID: 3632251
-
Diurnal changes in dopamine-beta-hydroxylase, homovanillic acid and 3-methoxy-4-hydroxyphenylglycol in serum of man.J Neural Transm. 1976;39(1-2):79-93. doi: 10.1007/BF01248767. J Neural Transm. 1976. PMID: 988114
-
Time course of the corticosteroid-dopaminergic interaction during metyrapone and dexamethasone administration.Psychiatry Res. 1995 Sep 8;58(1):23-35. doi: 10.1016/0165-1781(95)02646-e. Psychiatry Res. 1995. PMID: 8539309
-
A new approach to biochemical evaluation of brain dopamine metabolism.Cell Mol Neurobiol. 1988 Jun;8(2):171-9. doi: 10.1007/BF00711243. Cell Mol Neurobiol. 1988. PMID: 3044592 Free PMC article. Review.
-
Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids.Psychoneuroendocrinology. 1994;19(3):233-55. doi: 10.1016/0306-4530(94)90064-7. Psychoneuroendocrinology. 1994. PMID: 7515507 Review.
Cited by
-
Anti-SS-A (Ro) antibody is positively associated with steroid-induced psychiatric events in systemic lupus erythematosus patients.Rheumatol Int. 2013 Jun;33(6):1437-42. doi: 10.1007/s00296-012-2557-3. Epub 2012 Nov 21. Rheumatol Int. 2013. PMID: 23179258
-
Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects.Sci Rep. 2015 Nov 3;5:15954. doi: 10.1038/srep15954. Sci Rep. 2015. PMID: 26526738 Free PMC article.
-
Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression.Neurotox Res. 2002 Aug-Sep;4(5-6):531-555. doi: 10.1080/1029842021000022115. Neurotox Res. 2002. PMID: 12754165
-
Changes in pituitary-adrenal activity affect the apomorphine- and cholecystokinin-8-induced changes in striatal dopamine release using microdialysis.J Neural Transm Gen Sect. 1990;81(3):183-94. doi: 10.1007/BF01245041. J Neural Transm Gen Sect. 1990. PMID: 2397084
-
Elevated prolactin responses to L-tryptophan infusion in medication-free depressed patients.Psychopharmacology (Berl). 2003 Aug;169(1):77-83. doi: 10.1007/s00213-003-1475-1. Epub 2003 May 1. Psychopharmacology (Berl). 2003. PMID: 12728300 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources